Workflow
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Arthur J. Gallagher (NYSE:AJG), AeroVironment (NASDAQ:AVAV)
Benzinga· 2025-12-19 13:02
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying AVAV stock? Here’s what analysts think:Read This Next:Photo via Shutterstock ...
Google Cloud lands deal with Palo Alto Networks 'approaching $10 billion,' per source
Reuters· 2025-12-19 13:02
Core Insights - Alphabet's cloud computing unit has expanded its partnership with cybersecurity company Palo Alto Networks, marking it as Google Cloud's largest security service to date [1] Company Summary - The partnership aims to enhance Google Cloud's security offerings, leveraging Palo Alto Networks' expertise in cybersecurity [1] - This collaboration is expected to provide customers with improved security solutions, addressing the growing demand for robust cloud security [1] Industry Summary - The cloud computing and cybersecurity sectors are increasingly converging, as companies seek comprehensive solutions to protect their digital assets [1] - The expansion of partnerships in this space indicates a trend towards integrated security services within cloud platforms [1]
Conagra Sales Decline as Consumer Spending Remains Challenged
WSJ· 2025-12-19 13:02
Conagra logged lower sales in its latest quarter as consumers continued to pull back on spending on its products. ...
Safe-Pro USA Appoints 20+ Year Defense and Protective Equipment Industry Leader as VP of Marketing and Sales as it Expands its Ballistics Business
Businesswire· 2025-12-19 13:01
AVENTURA, Fla.--(BUSINESS WIRE)--Safe Pro Group Inc. (Nasdaq: SPAI) ("Safe Pro†or the "Company†), a developer of artificial intelligence (AI)-enabled defense and security solutions, today announced that its ballistic protective products unit, Safe-Pro USA (SPUSA), has appointed Michael Wratten as its new Vice President of Marketing and Sales. This appointment is part of broad business development and expansion initiatives currently under way as it responds to the increased domestic need for ad. ...
AM Best upgrades Arch on diversification and outperformance
ReinsuranceNe.ws· 2025-12-19 13:00
AM Best has upgraded Arch Capital Group and its subsidiaries’ ratings, citing the firm’s strong operating performance and a proven track record of delivering superior underwriting results and investment returns, even during softer market conditions.Notably, AM Best has upgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “aa” (Superior) from “aa-” (Superior) and affirmed the Financial Strength Rating (FSR) of A+ (Superior) of Arch Reinsurance Ltd. (Arch) (Bermuda) and its strategic affiliates.The ...
Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX”
Globenewswire· 2025-12-19 13:00
ORLANDO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its plans to transfer the listing of its [Class A] common stock to the New York Stock Exchange (“NYSE”) from the Nasdaq Stock Market LLC (“Nasdaq”). Abacus expects to begin trading as a NYSE listed company on or about December 30, 2025, and will commence trading under new ticker symbol “ABX”. The Company’s [Class A] com ...
Eminence Capital Sends Letter to GPK Board of Directors Seeking Immediate Reinstatement of Mike Doss as CEO
Prnewswire· 2025-12-19 13:00
Views Board's Decision to Replace Doss as Misguided, Ill-timed, and Done Without Proper Diligence Believes that Chairman Phil Martens Wields Outsized Influence over GPK's Board, has Jeopardized Shareholder Value, and Should Resign Encourages Shareholders with Similar Concerns to Voice Them Eminence to Evaluate All Options to Ensure Board Is Comprised of Individuals Who Are Committed to Protecting Shareholder Value NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Eminence Capital, LP ("Eminence"), a private investmen ...
Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors
Globenewswire· 2025-12-19 13:00
Company announcement no. 57 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 45 14 14 00 19 December 2025 Page 1 Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors As communicated on 21 February 2025 in the notice convening the annual general meeting, Lars-Erik Brenøe will step down from the Board of Directors of Danske Bank A/S at the end of this year. After almost a decade of service, Lars-Erik Brenøe has notified the Board of his decision to step down, effective at 31 Dece ...
Amaero Receives US$3.0 Million Refractory Powder Order from Titomic
Globenewswire· 2025-12-19 13:00
MCDONALD, Tenn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to advise that it has received a Purchase Order from Titomic Limited (“Titomic”) in the amount of US$3.0 million for refractory alloy powders. The order has been received under the previous ...
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
Globenewswire· 2025-12-19 13:00
CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that its development partner, GSK, filed a New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, an investigational oral carbapenem antibiotic being developed for the treatment of co ...